Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
33.03
-0.22 (-0.66%)
Apr 2, 2026, 11:10 AM EDT - Market open

Collegium Pharmaceutical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,0491,468901981785629
Market Cap Growth
11.71%62.98%-8.17%24.91%24.91%-9.32%
Enterprise Value
1,6061,9871,6521,1601,157651.84
Last Close Price
33.0346.3028.6530.7823.2018.68
PE Ratio
19.1226.7615.4023.86-31.3510.04
Forward PE
4.556.114.545.574.014.57
PEG Ratio
-0.160.160.160.171.08
PS Ratio
1.351.881.431.731.692.27
PB Ratio
3.494.873.945.024.033.10
P/TBV Ratio
4.146.095.066.584.033.78
P/FCF Ratio
3.224.484.433.586.406.19
P/OCF Ratio
3.214.464.393.576.326.07
EV/Sales Ratio
2.062.552.622.052.492.35
EV/EBITDA Ratio
3.834.904.873.676.727.53
EV/EBIT Ratio
8.3111.069.726.9534.7336.98
EV/FCF Ratio
4.906.078.134.239.446.41
Debt / Equity Ratio
3.003.003.992.512.801.03
Debt / EBITDA Ratio
2.672.312.892.134.122.99
Debt / FCF Ratio
2.862.864.822.465.782.55
Net Debt / Equity Ratio
1.821.823.571.862.750.36
Net Debt / EBITDA Ratio
1.571.362.411.153.110.84
Net Debt / FCF Ratio
1.681.684.021.334.370.71
Asset Turnover
0.470.470.450.490.500.41
Inventory Turnover
8.308.307.496.107.967.65
Quick Ratio
1.361.360.771.070.821.05
Current Ratio
1.571.570.951.170.971.13
Return on Equity (ROE)
23.70%23.70%32.62%24.68%-12.57%36.77%
Return on Assets (ROA)
7.34%7.34%8.50%9.16%3.09%-55.94%
Return on Invested Capital (ROIC)
12.41%12.41%14.50%16.47%5.74%-134.95%
Return on Capital Employed (ROCE)
15.15%15.15%18.47%23.42%5.78%4.32%
Earnings Yield
5.95%3.74%6.49%4.19%-3.19%9.96%
FCF Yield
31.03%22.31%22.57%27.96%15.61%16.16%
Buyback Yield / Dilution
1.79%1.79%3.26%-23.53%17.58%-16.77%
Total Shareholder Return
1.79%1.79%3.26%-23.53%17.58%-16.77%
Updated Feb 26, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q